Merck (UKEX:MRK) Other Long-Term Liabilities : ₴330,051 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Merck Other Long-Term Liabilities?

Merck's other long-term liabilities for the quarter that ended in Mar. 2024 was ₴330,051 Mil.

Merck's quarterly other long-term liabilities increased from Sep. 2023 (₴293,339 Mil) to Dec. 2023 (₴351,224 Mil) but then declined from Dec. 2023 (₴351,224 Mil) to Mar. 2024 (₴330,051 Mil).

Merck's annual other long-term liabilities declined from Dec. 2021 (₴376,870 Mil) to Dec. 2022 (₴332,488 Mil) but then increased from Dec. 2022 (₴332,488 Mil) to Dec. 2023 (₴351,224 Mil).

Merck Other Long-Term Liabilities Historical Data

The historical data trend for Merck's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merck Other Long-Term Liabilities Chart

Merck Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long-Term Liabilities

Get a 7-Day Free Trial

Merck Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Long-Term Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Merck Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Merck Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Merck's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Merck (UKEX:MRK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck & Co Inc (UKEX:MRK) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

MRK:USA MRK:Peru MRK:Mexico 1MRKX:Italy 6MKd:UK 0QAH:UK 6MK:Germany MRK:Chile MRCK34:Brazil MRK:Austria MRK:Argentina

Address

126 East Lincoln Avenue, Rahway, NJ, USA, 07065

Website

https://www.merck.com

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.